Artificial urinary sphincter: current status and future directions

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:zfgzfgzfg
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Urge urinary incontinence (UUl) is one of the most troublesome complications of surgery of the prostate whether for malignancy or benign conditions.For many decades,there have been attempts to reduce the morbidity of this outcome with variable results.Since its development in the 1970s,the artificial urinary sphincter (AUS) has been the “gold standard” for treatment of the most severe cases of UUl.Other attempts including injectable bulking agents,previous sphincter designs,and slings have been developed,but largely abandoned because of poor long-term efficacy and significant complications.The AUS has had several sentinel redesigns since its first introduction to reduce erosion and infection and increase efficacy.None of these changes in the basic AUS design have occurred in the past three decades,and the AUS remains the same despite newer technology and materials that could improve its function and safety.Recently,newer compressive devices and slings to reposition the bladder neck for men with mildto-moderate UUI have been developed with success in select patients.Similarly,the AUS has had applied antibiotic coating to all portions except the pressure-regulating balloon (PRB) to reduce infection risk.The basic AUS design,however,has not changed.With newer electronic technology,the concept of the electronic AUS or eAUS has been proposed and several possible iterations of this eAUS have been reported.While the eAUS is as yet not available,its development continues and a prototype device may be available soon.Possible design options are discussed in this review.
其他文献
Stem cells hold great promise for regenerative medicine because of their ability to self-renew and to differentiate into various cell types. Although embryonic stem cells (BSC) have greater differentiation potential than adult stem cells, the former is la
Aim: To investigate human epidermal growth factor receptor type 2 (HER2) protein expression and gene amplification in Chinese metastatic prostate cancer patients and their potential value as prognostic factors. Methods: Immuno-histochemistry (IHC) was per
Prostate cancer is among the most common malignancies in Western countries,and its incidence is rapidly rising in Asia where it was traditionally considered an uncommon tumor.Our understanding of the disease and management strategies continue to evolve.Th
期刊
The prognostic significance of initial prostate-specific antigen (PSA) level for metastatic prostate cancer remains uncertain. We investigated the differences in prognosis and response to hormonal therapies of metastatic prostate cancer patients according
Dear Editor,rnCongenital bilateral absence of the vas deferens (CBAVD),a complete or partial defect of the Wolffian duct derivatives,is found in >25% of men with obstructive azoospermia (OA),but the underlying pathological mechanism remains poorly underst
期刊
Dear Editor,rnIntrauterine insemination (IUI) is mainly indicated in cases of unexplained or mild male subfertility. In these cases, gonadotropin ovarian stimulation combined with gonadotropin-releasing hormone (GnRH) antagonist IUI leads to up to an 18%
期刊
Late-onset hypogonadism (LOH) has been described as a clinical syndrome comprising symptoms consistent with androgen deficiency and a circulating concentration of testosterone in the low-to-normal range insome middle-aged and elderly men.
期刊
The current literature does not support the usefulness of clinical markers on predicting which patients with atypical small acinar proliferation (ASAP) are more likely to progress to prostate cancer (PCa). Androgens have long been considered to be the pot